nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosphenytoin—CYP2C8—Mometasone—systemic scleroderma	0.153	0.238	CbGbCtD
Fosphenytoin—ALB—Captopril—systemic scleroderma	0.1	0.156	CbGbCtD
Fosphenytoin—ALB—Mycophenolate mofetil—systemic scleroderma	0.0788	0.123	CbGbCtD
Fosphenytoin—CYP2C9—Leflunomide—systemic scleroderma	0.0687	0.107	CbGbCtD
Fosphenytoin—ALB—Prednisone—systemic scleroderma	0.063	0.0982	CbGbCtD
Fosphenytoin—CYP2C8—Mycophenolate mofetil—systemic scleroderma	0.0609	0.0949	CbGbCtD
Fosphenytoin—CYP2C19—Prednisone—systemic scleroderma	0.0408	0.0637	CbGbCtD
Fosphenytoin—ALB—Methotrexate—systemic scleroderma	0.0316	0.0493	CbGbCtD
Fosphenytoin—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0247	0.0385	CbGbCtD
Fosphenytoin—CYP3A4—Prednisone—systemic scleroderma	0.0197	0.0308	CbGbCtD
Fosphenytoin—Leukopenia—Lisinopril—systemic scleroderma	0.000255	0.000711	CcSEcCtD
Fosphenytoin—Shock—Mycophenolic acid—systemic scleroderma	0.000254	0.000708	CcSEcCtD
Fosphenytoin—Hypotension—Leflunomide—systemic scleroderma	0.000253	0.000705	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.000253	0.000705	CcSEcCtD
Fosphenytoin—Tachycardia—Mycophenolic acid—systemic scleroderma	0.000252	0.000702	CcSEcCtD
Fosphenytoin—Palpitations—Lisinopril—systemic scleroderma	0.000252	0.000702	CcSEcCtD
Fosphenytoin—Loss of consciousness—Lisinopril—systemic scleroderma	0.000251	0.000698	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.00025	0.000696	CcSEcCtD
Fosphenytoin—Cough—Lisinopril—systemic scleroderma	0.000249	0.000693	CcSEcCtD
Fosphenytoin—Muscular weakness—Prednisone—systemic scleroderma	0.000248	0.000691	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.000247	0.000687	CcSEcCtD
Fosphenytoin—Anorexia—Mycophenolic acid—systemic scleroderma	0.000246	0.000686	CcSEcCtD
Fosphenytoin—Flatulence—Mycophenolate mofetil—systemic scleroderma	0.000246	0.000686	CcSEcCtD
Fosphenytoin—Tension—Mycophenolate mofetil—systemic scleroderma	0.000245	0.000683	CcSEcCtD
Fosphenytoin—Insomnia—Leflunomide—systemic scleroderma	0.000245	0.000682	CcSEcCtD
Fosphenytoin—Dysgeusia—Mycophenolate mofetil—systemic scleroderma	0.000245	0.000681	CcSEcCtD
Fosphenytoin—Paraesthesia—Leflunomide—systemic scleroderma	0.000243	0.000677	CcSEcCtD
Fosphenytoin—Anaphylactoid reaction—Methotrexate—systemic scleroderma	0.000243	0.000676	CcSEcCtD
Fosphenytoin—Arthralgia—Lisinopril—systemic scleroderma	0.000243	0.000676	CcSEcCtD
Fosphenytoin—Myalgia—Lisinopril—systemic scleroderma	0.000243	0.000676	CcSEcCtD
Fosphenytoin—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.000243	0.000676	CcSEcCtD
Fosphenytoin—Back pain—Mycophenolate mofetil—systemic scleroderma	0.000242	0.000673	CcSEcCtD
Fosphenytoin—Dyspnoea—Leflunomide—systemic scleroderma	0.000241	0.000672	CcSEcCtD
Fosphenytoin—Hypotension—Mycophenolic acid—systemic scleroderma	0.000241	0.000672	CcSEcCtD
Fosphenytoin—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.00024	0.000669	CcSEcCtD
Fosphenytoin—Discomfort—Lisinopril—systemic scleroderma	0.00024	0.000668	CcSEcCtD
Fosphenytoin—Dyspepsia—Leflunomide—systemic scleroderma	0.000238	0.000664	CcSEcCtD
Fosphenytoin—Vomiting—Mometasone—systemic scleroderma	0.000238	0.000663	CcSEcCtD
Fosphenytoin—Dry mouth—Lisinopril—systemic scleroderma	0.000237	0.000661	CcSEcCtD
Fosphenytoin—Feeling abnormal—Azathioprine—systemic scleroderma	0.000236	0.000658	CcSEcCtD
Fosphenytoin—Rash—Mometasone—systemic scleroderma	0.000236	0.000657	CcSEcCtD
Fosphenytoin—Asthenia—Captopril—systemic scleroderma	0.000236	0.000657	CcSEcCtD
Fosphenytoin—Dermatitis—Mometasone—systemic scleroderma	0.000236	0.000656	CcSEcCtD
Fosphenytoin—Decreased appetite—Leflunomide—systemic scleroderma	0.000235	0.000656	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000235	0.000656	CcSEcCtD
Fosphenytoin—Osteoarthritis—Methotrexate—systemic scleroderma	0.000235	0.000655	CcSEcCtD
Fosphenytoin—Confusional state—Lisinopril—systemic scleroderma	0.000235	0.000654	CcSEcCtD
Fosphenytoin—Headache—Mometasone—systemic scleroderma	0.000234	0.000653	CcSEcCtD
Fosphenytoin—Tremor—Mycophenolate mofetil—systemic scleroderma	0.000234	0.000652	CcSEcCtD
Fosphenytoin—Insomnia—Mycophenolic acid—systemic scleroderma	0.000234	0.000651	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000233	0.000648	CcSEcCtD
Fosphenytoin—Pruritus—Captopril—systemic scleroderma	0.000232	0.000648	CcSEcCtD
Fosphenytoin—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000232	0.000646	CcSEcCtD
Fosphenytoin—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000232	0.000646	CcSEcCtD
Fosphenytoin—Constipation—Leflunomide—systemic scleroderma	0.000232	0.000645	CcSEcCtD
Fosphenytoin—Infection—Lisinopril—systemic scleroderma	0.000231	0.000644	CcSEcCtD
Fosphenytoin—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000231	0.000643	CcSEcCtD
Fosphenytoin—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.00023	0.000642	CcSEcCtD
Fosphenytoin—Somnolence—Mycophenolic acid—systemic scleroderma	0.00023	0.00064	CcSEcCtD
Fosphenytoin—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000229	0.000639	CcSEcCtD
Fosphenytoin—Shock—Lisinopril—systemic scleroderma	0.000229	0.000638	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000228	0.000635	CcSEcCtD
Fosphenytoin—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000227	0.000633	CcSEcCtD
Fosphenytoin—Tachycardia—Lisinopril—systemic scleroderma	0.000227	0.000633	CcSEcCtD
Fosphenytoin—Body temperature increased—Azathioprine—systemic scleroderma	0.000227	0.000631	CcSEcCtD
Fosphenytoin—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000225	0.000627	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000225	0.000627	CcSEcCtD
Fosphenytoin—Diarrhoea—Captopril—systemic scleroderma	0.000225	0.000626	CcSEcCtD
Fosphenytoin—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000225	0.000626	CcSEcCtD
Fosphenytoin—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000224	0.000625	CcSEcCtD
Fosphenytoin—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000224	0.000624	CcSEcCtD
Fosphenytoin—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000224	0.000623	CcSEcCtD
Fosphenytoin—Feeling abnormal—Leflunomide—systemic scleroderma	0.000223	0.000622	CcSEcCtD
Fosphenytoin—Mood swings—Methotrexate—systemic scleroderma	0.000223	0.00062	CcSEcCtD
Fosphenytoin—Nausea—Mometasone—systemic scleroderma	0.000222	0.000619	CcSEcCtD
Fosphenytoin—Anorexia—Lisinopril—systemic scleroderma	0.000222	0.000618	CcSEcCtD
Fosphenytoin—Ataxia—Methotrexate—systemic scleroderma	0.000221	0.000615	CcSEcCtD
Fosphenytoin—Constipation—Mycophenolic acid—systemic scleroderma	0.000221	0.000615	CcSEcCtD
Fosphenytoin—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000221	0.000615	CcSEcCtD
Fosphenytoin—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000219	0.000612	CcSEcCtD
Fosphenytoin—Hyperglycaemia—Prednisone—systemic scleroderma	0.000219	0.000611	CcSEcCtD
Fosphenytoin—Cough—Mycophenolate mofetil—systemic scleroderma	0.000218	0.000607	CcSEcCtD
Fosphenytoin—Hypotension—Lisinopril—systemic scleroderma	0.000217	0.000606	CcSEcCtD
Fosphenytoin—Dizziness—Captopril—systemic scleroderma	0.000217	0.000605	CcSEcCtD
Fosphenytoin—Liver function test abnormal—Methotrexate—systemic scleroderma	0.000217	0.000604	CcSEcCtD
Fosphenytoin—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000216	0.000603	CcSEcCtD
Fosphenytoin—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000216	0.000601	CcSEcCtD
Fosphenytoin—Urticaria—Leflunomide—systemic scleroderma	0.000215	0.000599	CcSEcCtD
Fosphenytoin—Body temperature increased—Leflunomide—systemic scleroderma	0.000214	0.000596	CcSEcCtD
Fosphenytoin—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000213	0.000593	CcSEcCtD
Fosphenytoin—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000213	0.000592	CcSEcCtD
Fosphenytoin—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000213	0.000592	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000212	0.00059	CcSEcCtD
Fosphenytoin—Insomnia—Lisinopril—systemic scleroderma	0.00021	0.000586	CcSEcCtD
Fosphenytoin—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.00021	0.000585	CcSEcCtD
Fosphenytoin—Paraesthesia—Lisinopril—systemic scleroderma	0.000209	0.000582	CcSEcCtD
Fosphenytoin—Vomiting—Captopril—systemic scleroderma	0.000209	0.000582	CcSEcCtD
Fosphenytoin—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000208	0.000579	CcSEcCtD
Fosphenytoin—Dyspnoea—Lisinopril—systemic scleroderma	0.000207	0.000578	CcSEcCtD
Fosphenytoin—Rash—Captopril—systemic scleroderma	0.000207	0.000577	CcSEcCtD
Fosphenytoin—Dermatitis—Captopril—systemic scleroderma	0.000207	0.000577	CcSEcCtD
Fosphenytoin—Somnolence—Lisinopril—systemic scleroderma	0.000207	0.000576	CcSEcCtD
Fosphenytoin—Headache—Captopril—systemic scleroderma	0.000206	0.000573	CcSEcCtD
Fosphenytoin—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000206	0.000573	CcSEcCtD
Fosphenytoin—Dyspepsia—Lisinopril—systemic scleroderma	0.000205	0.000571	CcSEcCtD
Fosphenytoin—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000204	0.000569	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000204	0.000568	CcSEcCtD
Fosphenytoin—Asthma—Methotrexate—systemic scleroderma	0.000203	0.000566	CcSEcCtD
Fosphenytoin—Infection—Mycophenolate mofetil—systemic scleroderma	0.000202	0.000564	CcSEcCtD
Fosphenytoin—Decreased appetite—Lisinopril—systemic scleroderma	0.000202	0.000563	CcSEcCtD
Fosphenytoin—Shock—Mycophenolate mofetil—systemic scleroderma	0.000201	0.000559	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.0002	0.000556	CcSEcCtD
Fosphenytoin—Constipation—Lisinopril—systemic scleroderma	0.000199	0.000554	CcSEcCtD
Fosphenytoin—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000199	0.000554	CcSEcCtD
Fosphenytoin—Bradycardia—Prednisone—systemic scleroderma	0.000198	0.000552	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000197	0.000549	CcSEcCtD
Fosphenytoin—Diarrhoea—Azathioprine—systemic scleroderma	0.000196	0.000546	CcSEcCtD
Fosphenytoin—Nausea—Captopril—systemic scleroderma	0.000195	0.000544	CcSEcCtD
Fosphenytoin—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000194	0.000541	CcSEcCtD
Fosphenytoin—Asthenia—Leflunomide—systemic scleroderma	0.000194	0.000541	CcSEcCtD
Fosphenytoin—Feeling abnormal—Lisinopril—systemic scleroderma	0.000192	0.000534	CcSEcCtD
Fosphenytoin—Pruritus—Leflunomide—systemic scleroderma	0.000192	0.000534	CcSEcCtD
Fosphenytoin—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.00019	0.000531	CcSEcCtD
Fosphenytoin—Dysuria—Methotrexate—systemic scleroderma	0.00019	0.000529	CcSEcCtD
Fosphenytoin—Dizziness—Azathioprine—systemic scleroderma	0.00019	0.000528	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000186	0.000517	CcSEcCtD
Fosphenytoin—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000185	0.000516	CcSEcCtD
Fosphenytoin—Asthenia—Mycophenolic acid—systemic scleroderma	0.000185	0.000516	CcSEcCtD
Fosphenytoin—Diarrhoea—Leflunomide—systemic scleroderma	0.000185	0.000516	CcSEcCtD
Fosphenytoin—Urticaria—Lisinopril—systemic scleroderma	0.000185	0.000515	CcSEcCtD
Fosphenytoin—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000184	0.000514	CcSEcCtD
Fosphenytoin—Body temperature increased—Lisinopril—systemic scleroderma	0.000184	0.000512	CcSEcCtD
Fosphenytoin—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000183	0.00051	CcSEcCtD
Fosphenytoin—Pruritus—Mycophenolic acid—systemic scleroderma	0.000183	0.000509	CcSEcCtD
Fosphenytoin—Vomiting—Azathioprine—systemic scleroderma	0.000182	0.000508	CcSEcCtD
Fosphenytoin—Pneumonia—Methotrexate—systemic scleroderma	0.000182	0.000507	CcSEcCtD
Fosphenytoin—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000182	0.000506	CcSEcCtD
Fosphenytoin—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000181	0.000505	CcSEcCtD
Fosphenytoin—Rash—Azathioprine—systemic scleroderma	0.000181	0.000504	CcSEcCtD
Fosphenytoin—Dermatitis—Azathioprine—systemic scleroderma	0.000181	0.000503	CcSEcCtD
Fosphenytoin—Headache—Azathioprine—systemic scleroderma	0.00018	0.0005	CcSEcCtD
Fosphenytoin—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000179	0.0005	CcSEcCtD
Fosphenytoin—Dizziness—Leflunomide—systemic scleroderma	0.000179	0.000499	CcSEcCtD
Fosphenytoin—Renal failure—Methotrexate—systemic scleroderma	0.000178	0.000496	CcSEcCtD
Fosphenytoin—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000177	0.000494	CcSEcCtD
Fosphenytoin—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000177	0.000492	CcSEcCtD
Fosphenytoin—Conjunctivitis—Methotrexate—systemic scleroderma	0.000176	0.00049	CcSEcCtD
Fosphenytoin—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000174	0.000486	CcSEcCtD
Fosphenytoin—Sweating—Methotrexate—systemic scleroderma	0.000174	0.000484	CcSEcCtD
Fosphenytoin—Vomiting—Leflunomide—systemic scleroderma	0.000172	0.00048	CcSEcCtD
Fosphenytoin—Dizziness—Mycophenolic acid—systemic scleroderma	0.000171	0.000476	CcSEcCtD
Fosphenytoin—Epistaxis—Methotrexate—systemic scleroderma	0.000171	0.000476	CcSEcCtD
Fosphenytoin—Rash—Leflunomide—systemic scleroderma	0.000171	0.000476	CcSEcCtD
Fosphenytoin—Dermatitis—Leflunomide—systemic scleroderma	0.000171	0.000475	CcSEcCtD
Fosphenytoin—Nausea—Azathioprine—systemic scleroderma	0.00017	0.000474	CcSEcCtD
Fosphenytoin—Headache—Leflunomide—systemic scleroderma	0.00017	0.000473	CcSEcCtD
Fosphenytoin—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000168	0.000468	CcSEcCtD
Fosphenytoin—Asthenia—Lisinopril—systemic scleroderma	0.000167	0.000465	CcSEcCtD
Fosphenytoin—Pruritus—Lisinopril—systemic scleroderma	0.000165	0.000459	CcSEcCtD
Fosphenytoin—Vomiting—Mycophenolic acid—systemic scleroderma	0.000164	0.000458	CcSEcCtD
Fosphenytoin—Rash—Mycophenolic acid—systemic scleroderma	0.000163	0.000454	CcSEcCtD
Fosphenytoin—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000163	0.000453	CcSEcCtD
Fosphenytoin—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000162	0.000451	CcSEcCtD
Fosphenytoin—Headache—Mycophenolic acid—systemic scleroderma	0.000162	0.000451	CcSEcCtD
Fosphenytoin—Pharyngitis—Methotrexate—systemic scleroderma	0.000161	0.000449	CcSEcCtD
Fosphenytoin—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000161	0.000449	CcSEcCtD
Fosphenytoin—Nausea—Leflunomide—systemic scleroderma	0.000161	0.000448	CcSEcCtD
Fosphenytoin—Diarrhoea—Lisinopril—systemic scleroderma	0.000159	0.000443	CcSEcCtD
Fosphenytoin—Ill-defined disorder—Prednisone—systemic scleroderma	0.000157	0.000438	CcSEcCtD
Fosphenytoin—Anaemia—Prednisone—systemic scleroderma	0.000156	0.000436	CcSEcCtD
Fosphenytoin—Agitation—Prednisone—systemic scleroderma	0.000156	0.000433	CcSEcCtD
Fosphenytoin—Dizziness—Lisinopril—systemic scleroderma	0.000154	0.000429	CcSEcCtD
Fosphenytoin—Nausea—Mycophenolic acid—systemic scleroderma	0.000153	0.000427	CcSEcCtD
Fosphenytoin—Malaise—Prednisone—systemic scleroderma	0.000153	0.000425	CcSEcCtD
Fosphenytoin—Vertigo—Prednisone—systemic scleroderma	0.000152	0.000424	CcSEcCtD
Fosphenytoin—Syncope—Prednisone—systemic scleroderma	0.000152	0.000423	CcSEcCtD
Fosphenytoin—Tinnitus—Methotrexate—systemic scleroderma	0.000152	0.000422	CcSEcCtD
Fosphenytoin—Loss of consciousness—Prednisone—systemic scleroderma	0.000149	0.000415	CcSEcCtD
Fosphenytoin—Vomiting—Lisinopril—systemic scleroderma	0.000148	0.000412	CcSEcCtD
Fosphenytoin—Rash—Lisinopril—systemic scleroderma	0.000147	0.000409	CcSEcCtD
Fosphenytoin—Convulsion—Prednisone—systemic scleroderma	0.000147	0.000409	CcSEcCtD
Fosphenytoin—Dermatitis—Lisinopril—systemic scleroderma	0.000147	0.000408	CcSEcCtD
Fosphenytoin—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000146	0.000407	CcSEcCtD
Fosphenytoin—Hypertension—Prednisone—systemic scleroderma	0.000146	0.000407	CcSEcCtD
Fosphenytoin—Chills—Methotrexate—systemic scleroderma	0.000146	0.000406	CcSEcCtD
Fosphenytoin—Headache—Lisinopril—systemic scleroderma	0.000146	0.000406	CcSEcCtD
Fosphenytoin—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000144	0.000402	CcSEcCtD
Fosphenytoin—Arthralgia—Prednisone—systemic scleroderma	0.000144	0.000402	CcSEcCtD
Fosphenytoin—Myalgia—Prednisone—systemic scleroderma	0.000144	0.000402	CcSEcCtD
Fosphenytoin—Discomfort—Prednisone—systemic scleroderma	0.000142	0.000397	CcSEcCtD
Fosphenytoin—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000139	0.000389	CcSEcCtD
Fosphenytoin—Dysgeusia—Methotrexate—systemic scleroderma	0.000139	0.000386	CcSEcCtD
Fosphenytoin—Nausea—Lisinopril—systemic scleroderma	0.000138	0.000385	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Prednisone—systemic scleroderma	0.000138	0.000385	CcSEcCtD
Fosphenytoin—Infection—Prednisone—systemic scleroderma	0.000137	0.000382	CcSEcCtD
Fosphenytoin—Back pain—Methotrexate—systemic scleroderma	0.000137	0.000381	CcSEcCtD
Fosphenytoin—Shock—Prednisone—systemic scleroderma	0.000136	0.000379	CcSEcCtD
Fosphenytoin—Tachycardia—Prednisone—systemic scleroderma	0.000135	0.000376	CcSEcCtD
Fosphenytoin—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000135	0.000376	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Prednisone—systemic scleroderma	0.000134	0.000372	CcSEcCtD
Fosphenytoin—Anorexia—Prednisone—systemic scleroderma	0.000132	0.000367	CcSEcCtD
Fosphenytoin—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000131	0.000366	CcSEcCtD
Fosphenytoin—Anaemia—Methotrexate—systemic scleroderma	0.000131	0.000364	CcSEcCtD
Fosphenytoin—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.00013	0.000361	CcSEcCtD
Fosphenytoin—Rash—Mycophenolate mofetil—systemic scleroderma	0.000129	0.000358	CcSEcCtD
Fosphenytoin—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000128	0.000358	CcSEcCtD
Fosphenytoin—Headache—Mycophenolate mofetil—systemic scleroderma	0.000128	0.000356	CcSEcCtD
Fosphenytoin—Malaise—Methotrexate—systemic scleroderma	0.000128	0.000355	CcSEcCtD
Fosphenytoin—Vertigo—Methotrexate—systemic scleroderma	0.000127	0.000354	CcSEcCtD
Fosphenytoin—Leukopenia—Methotrexate—systemic scleroderma	0.000127	0.000353	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000126	0.000351	CcSEcCtD
Fosphenytoin—Insomnia—Prednisone—systemic scleroderma	0.000125	0.000348	CcSEcCtD
Fosphenytoin—Paraesthesia—Prednisone—systemic scleroderma	0.000124	0.000346	CcSEcCtD
Fosphenytoin—Cough—Methotrexate—systemic scleroderma	0.000123	0.000344	CcSEcCtD
Fosphenytoin—Convulsion—Methotrexate—systemic scleroderma	0.000123	0.000342	CcSEcCtD
Fosphenytoin—Dyspepsia—Prednisone—systemic scleroderma	0.000122	0.000339	CcSEcCtD
Fosphenytoin—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000121	0.000337	CcSEcCtD
Fosphenytoin—Arthralgia—Methotrexate—systemic scleroderma	0.00012	0.000336	CcSEcCtD
Fosphenytoin—Myalgia—Methotrexate—systemic scleroderma	0.00012	0.000336	CcSEcCtD
Fosphenytoin—Decreased appetite—Prednisone—systemic scleroderma	0.00012	0.000335	CcSEcCtD
Fosphenytoin—Discomfort—Methotrexate—systemic scleroderma	0.000119	0.000332	CcSEcCtD
Fosphenytoin—Constipation—Prednisone—systemic scleroderma	0.000118	0.000329	CcSEcCtD
Fosphenytoin—Confusional state—Methotrexate—systemic scleroderma	0.000116	0.000324	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000115	0.000322	CcSEcCtD
Fosphenytoin—Infection—Methotrexate—systemic scleroderma	0.000115	0.00032	CcSEcCtD
Fosphenytoin—Feeling abnormal—Prednisone—systemic scleroderma	0.000114	0.000317	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000113	0.000315	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000112	0.000311	CcSEcCtD
Fosphenytoin—Anorexia—Methotrexate—systemic scleroderma	0.00011	0.000307	CcSEcCtD
Fosphenytoin—Urticaria—Prednisone—systemic scleroderma	0.00011	0.000306	CcSEcCtD
Fosphenytoin—Body temperature increased—Prednisone—systemic scleroderma	0.000109	0.000304	CcSEcCtD
Fosphenytoin—Hypotension—Methotrexate—systemic scleroderma	0.000108	0.000301	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000105	0.000293	CcSEcCtD
Fosphenytoin—Insomnia—Methotrexate—systemic scleroderma	0.000104	0.000291	CcSEcCtD
Fosphenytoin—Paraesthesia—Methotrexate—systemic scleroderma	0.000104	0.000289	CcSEcCtD
Fosphenytoin—Dyspnoea—Methotrexate—systemic scleroderma	0.000103	0.000287	CcSEcCtD
Fosphenytoin—Somnolence—Methotrexate—systemic scleroderma	0.000103	0.000286	CcSEcCtD
Fosphenytoin—Dyspepsia—Methotrexate—systemic scleroderma	0.000102	0.000283	CcSEcCtD
Fosphenytoin—Decreased appetite—Methotrexate—systemic scleroderma	0.0001	0.00028	CcSEcCtD
Fosphenytoin—Asthenia—Prednisone—systemic scleroderma	9.91e-05	0.000276	CcSEcCtD
Fosphenytoin—Pruritus—Prednisone—systemic scleroderma	9.77e-05	0.000272	CcSEcCtD
Fosphenytoin—Feeling abnormal—Methotrexate—systemic scleroderma	9.51e-05	0.000265	CcSEcCtD
Fosphenytoin—Diarrhoea—Prednisone—systemic scleroderma	9.45e-05	0.000263	CcSEcCtD
Fosphenytoin—Urticaria—Methotrexate—systemic scleroderma	9.17e-05	0.000256	CcSEcCtD
Fosphenytoin—Dizziness—Prednisone—systemic scleroderma	9.14e-05	0.000255	CcSEcCtD
Fosphenytoin—Body temperature increased—Methotrexate—systemic scleroderma	9.13e-05	0.000254	CcSEcCtD
Fosphenytoin—Vomiting—Prednisone—systemic scleroderma	8.78e-05	0.000245	CcSEcCtD
Fosphenytoin—Rash—Prednisone—systemic scleroderma	8.71e-05	0.000243	CcSEcCtD
Fosphenytoin—Dermatitis—Prednisone—systemic scleroderma	8.7e-05	0.000242	CcSEcCtD
Fosphenytoin—Headache—Prednisone—systemic scleroderma	8.66e-05	0.000241	CcSEcCtD
Fosphenytoin—Asthenia—Methotrexate—systemic scleroderma	8.28e-05	0.000231	CcSEcCtD
Fosphenytoin—Nausea—Prednisone—systemic scleroderma	8.21e-05	0.000229	CcSEcCtD
Fosphenytoin—Pruritus—Methotrexate—systemic scleroderma	8.17e-05	0.000228	CcSEcCtD
Fosphenytoin—Diarrhoea—Methotrexate—systemic scleroderma	7.9e-05	0.00022	CcSEcCtD
Fosphenytoin—Dizziness—Methotrexate—systemic scleroderma	7.64e-05	0.000213	CcSEcCtD
Fosphenytoin—Vomiting—Methotrexate—systemic scleroderma	7.34e-05	0.000205	CcSEcCtD
Fosphenytoin—Rash—Methotrexate—systemic scleroderma	7.28e-05	0.000203	CcSEcCtD
Fosphenytoin—Dermatitis—Methotrexate—systemic scleroderma	7.27e-05	0.000203	CcSEcCtD
Fosphenytoin—Headache—Methotrexate—systemic scleroderma	7.23e-05	0.000202	CcSEcCtD
Fosphenytoin—Nausea—Methotrexate—systemic scleroderma	6.86e-05	0.000191	CcSEcCtD
